Patents by Inventor Zhouning YANG

Zhouning YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260217850
    Abstract: Disclosed is a monoclonal antibody specifically binding to human CD38, or an antigen binding fragment thereof, wherein the monoclonal antibody binds to an extracellular domain of CD38 at amino acid residues comprising at least one amino acid residue selected from a group consisting of K25, E28, 129, M33, and R34, wherein the amino acid residue is numbered according to the amino acid sequence of the extracellular domain of CD38 as shown in SEQ ID NO: 36. Also disclosed is a pharmaceutical composition comprising the antibodies and medical uses thereof.
    Type: Application
    Filed: December 20, 2023
    Publication date: July 30, 2026
    Applicant: SOUND BIOPHARMACEUTICALS CO. LTD.
    Inventors: Fanxin Ma, Qing Li, Ying Huang, Xianda Zhang, Pengyu Chen, Zhouning Yang, Shuang Liu, Feng Qu, Chunmei Chen
  • Publication number: 20240400711
    Abstract: Provided are a monoclonal antibody binding to human CD38, an antigen-binding fragment thereof, a pharmaceutical composition comprising the same, and use thereof in the treatment of a CD38-positive cancer.
    Type: Application
    Filed: September 19, 2022
    Publication date: December 5, 2024
    Applicant: SOUND BIOPHARMACEUTICALS CO. LTD.
    Inventors: Fanxin MA, Qing LI, Ying HUANG, Xianda ZHANG, Pengyu CHEN, Zhouning YANG, Shuang LIU, Feng QU, Chunmei CHEN
  • Publication number: 20240382612
    Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.
    Type: Application
    Filed: April 26, 2024
    Publication date: November 21, 2024
    Inventors: Jiaqiang CAI, Shuai SONG, Tongtong XUE, Liang XIAO, Hanwen DENG, Qiang TIAN, Jing WANG, Dengnian LIU, Liping LIU, Haimin YU, Zhouning YANG, Xu CAO, Guoqing ZHONG, Lichun WANG, Jingyi WANG
  • Publication number: 20230357259
    Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.
    Type: Application
    Filed: January 17, 2023
    Publication date: November 9, 2023
    Inventors: Jiaqiang CAI, Shuai SONG, Tongtong XUE, Liang XIAO, Hanwen DENG, Qiang TIAN, Jing WANG, Dengnian LIU, Liping LIU, Haimin YU, Zhouning YANG, Xu CAO, Guoqing ZHONG, Lichun WANG, Jingyi WANG
  • Publication number: 20210101906
    Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.
    Type: Application
    Filed: December 10, 2018
    Publication date: April 8, 2021
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Jiaqiang CAI, Shuai SONG, Tongtong XUE, Liang XIAO, Hanwen DENG, Qiang TIAN, Jing WANG, Dengnian LIU, Liping Liu, Haimin YU, Zhouning YANG, Xu CAO, Guoqing ZHONG, Lichun WANG, Jingyi WANG
  • Publication number: 20200347075
    Abstract: The disclosure relates to a bioactive molecule conjugate, preparation methods and use thereof, particularly relates to a novel bioactive molecule conjugate obtained by improving coupling of the drug and the targeting moiety in an ADC or SMDC, as well as its preparation method and use in the manufacture of a medicament for the treatment of a disease associated with an abnormal cell activity.
    Type: Application
    Filed: December 10, 2018
    Publication date: November 5, 2020
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Jiaqiang CAI, Shuai SONG, Tongtong XUE, Liang XIAO, Hanwen DENG, Qiang TIAN, Jing WANG, Dengnian LIU, Liping Liu, Haimin YU, Zhouning YANG, Xu CAO, Guoqing ZHONG, Lichun WANG, Jingyi WANG